Haptoglobin polymorphism and mortality in patients with tuberculosis.

Area of Science:

• Genetics and infectious disease research.
• Clinical epidemiology and outcomes research.

Background:

• Haptoglobin (Hp) is a protein involved in hemoglobin binding and immune response.
• Understanding genetic factors influencing tuberculosis (TB) susceptibility and treatment outcomes is crucial.

Purpose of the Study:

• To investigate the association between haptoglobin (Hp) phenotypes and susceptibility to clinical pulmonary tuberculosis.
• To evaluate the impact of Hp phenotypes on treatment outcomes for pulmonary tuberculosis.

Main Methods:

• A case-control study and a prospective cohort study were conducted in rural Zimbabwe.
• 98 pulmonary tuberculosis patients and 98 matched controls were analyzed for Hp phenotype distribution.
• Treatment outcomes were followed for 18 months to assess mortality rates across different Hp phenotypes.

Main Results:

• No significant difference in Hp phenotype distribution was observed between tuberculosis patients and controls.
• Mortality rates during follow-up were higher for patients with Hp 2-2 phenotype (33%) compared to Hp 2-1 (19%) and Hp 1-1 (10%).
• Logistic regression indicated a 6.1-fold increased odds of dying for individuals with Hp 2-2 phenotype versus Hp 1-1.

Conclusions:

• Haptoglobin phenotypes do not appear to influence susceptibility to developing clinical pulmonary tuberculosis.
• The Hp 2-2 phenotype is associated with an increased risk of mortality among patients being treated for pulmonary tuberculosis.